Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 05, 2025

Get In Touch

Enhanced Recovery Feasible After Partial Nephrectomy Of Renal Malignancies Urology

Enhanced Recovery Feasible After Partial Nephrectomy Of Renal Malignancies

  • 17 July 2025
  • 3 months ago

What Are Criteria For Continuous Kidney Replacement Therapy Cessation In ICU Patients? Nephrology

What Are Criteria For Continuous Kidney Replacement Therapy Cessation In ICU Patients?

  • 17 July 2025
  • 3 months ago

In Septic ICU Patients, Lower Level Of All BP Components Linked To Higher Mortality, Myocardial And Acute Kidney Injury Nephrology

In Septic ICU Patients, Lower Level Of All BP Components Linked To Higher Mortality, Myocardial And Acute Kidney Injury

  • 17 July 2025
  • 3 months ago

PSA Screening Reduces Prostate Cancer Mortality Over 15 Years, Finds New Randomized Clinical Trial Urology

PSA Screening Reduces Prostate Cancer Mortality Over 15 Years, Finds New Randomized Clinical Trial

  • 17 July 2025
  • 3 months ago

Low BP During Hemodialysis Indicative Of Peripheral Vascular Disease: Study Nephrology

Low BP During Hemodialysis Indicative Of Peripheral Vascular Disease: Study

  • 17 July 2025
  • 3 months ago

Fecal Microbiota Transplantation Reduces Resistant Bacteria Colonization In Kidney Transplant Recipients Nephrology

Fecal Microbiota Transplantation Reduces Resistant Bacteria Colonization In Kidney Transplant Recipients

  • 17 July 2025
  • 3 months ago

Canagliflozin Does Not Impact Risk Of Neuropathy Events In Diabetics, Shows Data From CREDENCE Trial Nephrology

Canagliflozin Does Not Impact Risk Of Neuropathy Events In Diabetics, Shows Data From CREDENCE Trial

  • 17 July 2025
  • 3 months ago

BP Control And The Use Of RAAS-Blocking Agents In Diabetic Kidney Disease: UK Guidelines Nephrology

BP Control And The Use Of RAAS-Blocking Agents In Diabetic Kidney Disease: UK Guidelines

  • 17 July 2025
  • 3 months ago

DPP-4 Inhibitors And SGLT2 Inhibitors Effective In Diabetics After Kidney Transplant Nephrology

DPP-4 Inhibitors And SGLT2 Inhibitors Effective In Diabetics After Kidney Transplant

  • 17 July 2025
  • 3 months ago

Potential New Pathway And Enzyme Responsible For Thrombosis In CKD Identified In New Study Nephrology

Potential New Pathway And Enzyme Responsible For Thrombosis In CKD Identified In New Study

  • 17 July 2025
  • 3 months ago

Recent News

Gujarat MBBS, BDS Admissions 2025: Check round 3 a...

  • 05 November, 2025

DME Gujarat extends PG Ayurveda, Homeopathy round...

  • 05 November, 2025

NEET counselling: CENTAC publishes round 3 provisi...

  • 05 November, 2025

Marksans Pharma UK arm gets marketing nod for Exem...

  • 05 November, 2025

Zydus Wellness net sales up by 31 percent in Q2 FY...

  • 05 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.